Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Lidakol NDA accepted for review

March 17, 1998

Research to begin on new approach to antibiotic therapy

March 16, 1998

New antibacterial agents from Ortho

March 16, 1998

New methylcarbapenems from Sankyo

March 16, 1998

Omniferon enters preclinical studies

March 13, 1998

SKB reveals new antiherpesvirus agents

March 13, 1998

Sch-40832: a novel thiostrepton antimicrobial agent

March 12, 1998

FDA approves three-day treatment option for bacterial vaginosis

March 12, 1998

Macrolactine M described by Ocean Biotechnology

March 12, 1998

Cidofovir demonstrates anti-poxvirus activity in primates

March 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...